Fraxinus ornus
Connections displayed (default: 10).
Loading graph...
| Scientific Name | Fraxinus ornus |
|---|---|
| Iucn Redlist Category | Least Concern |
| Database Name | cmaup_plants;imppat_herbs;osadhi_herbs |
| Tropicos | http://www.tropicos.org/Name/23000369 |
| Pow | http://www.plantsoftheworldonline.org/taxon/urn:lsid:ipni.org:names:609128-1 |
| Mpns Kew | https://mpns.science.kew.org/mpns-portal/plantDetail?plantId=369914&query=Fraxinus+ornus&filter=&fuzzy=false&nameType=all&dbs=wcs |
| Synonyms | Fraxinus ornus, Fraxinus Ornus |
| Ipni Id | http://www.ipni.org/ipni/idPlantNameSearch.do?id=609128-1&back_page=%2Fipni%2FeditSimplePlantNameSearch.do%3Ffind_wholeName%3DFraxinus%2Bornus%26output_format%3Dnormal, NPO13914 |
| Plant List Id | http://www.theplantlist.org/tpl1.1/record/kew-369914 |
| Plant Name | Fraxinus ornus |
| Genus Tax Id | 38871 |
| Wfo | http://www.worldfloraonline.org/taxon/wfo-0000832712 |
| Frlht Plant Info | http://envis.frlht.org/plantdetails/75fff5fa40f42cd6957a24e82e21435a/e7496bd28934cccc5da4344b3a0fc6cb |
| Disease Name | Hyper-lipoproteinaemia, Rheumatoid arthritis, Breast cancer, Solid tumour/cancer, Psoriasis, Bacterial infection, Low bone mass disorder, Synthesis disorder, Acute/subacute hepatic failure, Crohn disease, Essential hypertension, Asthma, Renal cell carcinoma, Multiple sclerosis, Muscular dystrophy, Fungal infection, Diabetes mellitus, type unspecified, Type 2 diabetes mellitus, Lung cancer, Choreiform disorder, Atopic eczema, Mature T-cell lymphoma, Skin and skin-structure infection, Lupus erythematosus, Ewing sarcoma, Glaucoma, Peroxisomal disease, Substance abuse, Acute myeloid leukaemia, Chronic arterial occlusive disease, Indeterminate colitis, Heart failure, Seborrhoeic dermatitis, Duodenal ulcer, Malignant haematopoietic neoplasm, Irritable bowel syndrome, Myelodysplastic syndrome, Myeloproliferative neoplasm, Insomnia, Autoimmune disease, Bronchiectasis, Other specified increased intracranial pressure, Cerebral oedema, Cystic fibrosis, Oligodendroglioma, anaplastic, Wheezing, Postherpetic polyneuropathy, Opioid use disorder, coronary artery disease, Chronic myeloid leukaemia, NOS, Hearing disorder, Intracranial injury, unspecified, COVID-19, Maternal care for signs of fetal hypoxia, Obstructive sleep apnoea, Pulpitis, Malaria, Ischaemic/haemorrhagic stroke, Osteoarthritis, Metabolic disorder, Central nervous system disease, Chronic obstructive pulmonary disease, Pain, unspecified, Constipation, Prostate cancer, Chronic kidney disease, Exposure to or harmful effects of undetermined intent of other or unspecified substances chiefly nonmedicinal as to source, Brain cancer, Structural developmental anomaly of heart or great vessels, unspecified, Glioblastoma, primary, NOS, Hypotension, Malignant neoplasms of kidney, except renal pelvis, Primary sclerosing cholangitis, Sickle-cell disorder, Septic shock, Diabetic polyneuropathy, Unspecific body region injury, Carcinosarcoma of uterus, Serous cystadenoma,borderline malignancy of ovary, Pheochromocytoma, Osteoarthritis, unspecified, Malignant neoplasms of biliary tract, distal bile duct, Hepatoblastoma, Atrial fibrillation, Malignant neoplasm metastasis in lymph nodes of head, face or neck, Diffuse large B-cell lymphomas, Other specified malignant neoplasms of kidney, except renal pelvis, Keratoconus, Squamous cell carcinoma of bronchus or lung, Adenocarcinoma of pancreas, Mesothelioma of pleura, Pre-eclampsia, Tetralogy of Fallot, Other specified malignant neoplasms ofcolon, Melanoma of skin, Hepatocellular carcinoma of liver, Other specified malignant neoplasms of bronchus or lung, Superficial ovarian endometriosis, Urothelial carcinoma of bladder, Cytomegaloviral disease, Chronic rhinosinusitis, Malignant neoplasms of thyroid gland, unspecified, Adenocarcinoma of bronchus or lung, Malignant neoplasms of corpus uteri, unspecified, Chikungunya virus disease, Parkinson disease, Malignant neoplasms of thymus, Invasive carcinoma of breast, Glioblastoma of brain, Renal cell carcinoma, chromophobe type, Germ cell tumour of testis, Malignant neoplasms of adrenal gland |
| Species Name | Fraxinus ornus |
| System Of Medicine | Siddha, Unani |
| Genus Name | Fraxinus |
| Species Tax Id | 38874 |
| Disease Id | 5C80, FA20, 2C60-2C6Y, 2A00-2F9Z, EA90, 1A00-1C4Z, FB83, 5C52-5C59, DB91, DD70, BA00, CA23, 2C90, 8A40, 8C70, 1F29-1F2F, 5A14, 5A11, 2C25, 8A01, EA80, 2A90, 1F28-1G0Z, 4A40, 2B52, 9C61, 5C57, 6C40, 2A60, BD4Z, DD72, BD10-BD1Z, EA81, DA63, 2B33, DD91, 2A37, 2A20, 7A00-7A0Z, 4A40-4A45, CA24, 8D60.Y, 8D60.1, CA25, XH8844, MD11.C, 1E91.5, 6C43, BA8Y-BA8Z, XH4XG8, AB50-AB57, NA07.Z, 1D6Y, JA86.2, 7A41, DA09.0, 1F40-1F45, 8B20, FA00-FA05, 5C50-5D2Z, 8A04-8D87, CA22, MG3Z, ME05.0, 2C82, GB61, PH56, 2A00, LA8Z, XH0MB1, BA20-BA21, DB96.2, 3A51, XS26, 8C03.0, ND56, 2C76.43, 2C73.4, XH3854, FA0Z, 2C15, 2C12.01, BC81.3, 2D60.0, 2A81, 2C90.Y, 9A78.50, 2C25.2, 2C10.0, 2C26.0, JA24, LA88.2, 2B90.Y, 2C30, 2C12.02, 2C25.Y, GA10.B4, 2C94.2, 1D82, CA0A, 2D10.Z, 2C25.0, 2C76.Z, 1D40, 8A00.0, 2C27, 2C61, 2A00.00, XH6153, 2C80.2, 2D11 |
| Family Name | Oleaceae |
| Family Tax Id | 4144 |
| Group | Angiosperms |
- 1. (+)-Pisiferal (PubChem CID: 13785026)
- 2. (+)-Vestitol (PubChem CID: 177149)
- 3. (-)-Alpha-Curcumene (PubChem CID: 442360)
- 4. (13s,14e,15s)-14-Ethylidene-4,22-Dihydroxy-15-[(2s,3r,4s,5s,6r)-3,4,5-Trihydroxy-6-(Hydroxymethyl)oxan-2-Yl]oxy-2,10,16,20-Tetraoxatetracyclo[21.2.2.13,7.013,18]octacosa-1(25),3,5,7(28),17,23,26-Heptaene-11,19-Dione (PubChem CID: 21575881)
- 5. (13s,14e,15s)-15-[(2s,3r,4s,5r,6r)-3,5-Dihydroxy-6-(Hydroxymethyl)-4-[(2s,3r,4s,5s,6r)-3,4,5-Trihydroxy-6-(Hydroxymethyl)oxan-2-Yl]oxyoxan-2-Yl]oxy-14-Ethylidene-4-Hydroxy-2,10,16,20-Tetraoxatetracyclo[21.2.2.13,7.013,18]octacosa-1(25),3,5,7(28),17,23,26-Heptaene-11,19-Dione (PubChem CID: 100926586)
- 6. (24s)-5alpha-Cholestane-3beta,4beta,6beta,8,15beta,24-Hexaol (PubChem CID: 21630080)
- 7. (3s,3ar)-3-(Furan-3-Yl)-3a,7-Dimethyl-3,4,5,6-Tetrahydro-2-Benzofuran-1-One (PubChem CID: 776141)
- 8. (3s,4r,5s,6r,8s,9r,10s,13r,14s,15r,17r)-17-[(2r,4r,5s)-4,5-Dihydroxy-6-Methylheptan-2-Yl]-10,13-Dimethyl-1,2,3,4,5,6,7,9,11,12,14,15,16,17-Tetradecahydrocyclopenta[A]phenanthrene-3,4,6,8,15-Pentol (PubChem CID: 162985504)
- 9. (3s,4r,5s,6r,8s,9r,10s,13r,14s,15r,17r)-17-[(2r,5r)-5,6-Dihydroxy-6-Methylheptan-2-Yl]-10,13-Dimethyl-1,2,3,4,5,6,7,9,11,12,14,15,16,17-Tetradecahydrocyclopenta[A]phenanthrene-3,4,6,8,15-Pentol (PubChem CID: 44566288)
- 10. (3s,4r,5s,6r,8s,9r,10s,13r,14s,15r,17r)-17-[(2r,5s)-5-[(2r,3r,4r,5s)-3,4-Dihydroxy-5-(Hydroxymethyl)oxolan-2-Yl]oxy-6-Methylheptan-2-Yl]-3-[(2s,3r,4s,5r)-4-Hydroxy-3,5-Dimethoxyoxan-2-Yl]oxy-10,13-Dimethyl-1,2,3,4,5,6,7,9,11,12,14,15,16,17-Tetradecahydrocyclopenta[A]phenanthrene-4,6,8,15-Tetrol (PubChem CID: 162909864)
- 11. (3s,4r,5s,6r,8s,9r,10s,13r,14s,15r,17r)-17-[(2r,5s)-5-Hydroxy-6-Methylheptan-2-Yl]-10,13-Dimethyl-3-[(2s,3r,4s,5r)-3,4,5-Trimethoxyoxan-2-Yl]oxy-1,2,3,4,5,6,7,9,11,12,14,15,16,17-Tetradecahydrocyclopenta[A]phenanthrene-4,6,8,15-Tetrol (PubChem CID: 162907910)
- 12. (3s,4r,5s,6r,8s,9r,10s,13r,14s,15s,17r)-17-[(2r,5s)-5-[(2s,3s,4s,5r)-3,4-Dihydroxy-5-(Hydroxymethyl)oxolan-2-Yl]oxy-6-Methylheptan-2-Yl]-3-[(2s,3r,4s,5r)-4-Hydroxy-3,5-Dimethoxyoxan-2-Yl]oxy-10,13-Dimethyl-1,2,3,4,5,6,7,9,11,12,14,15,16,17-Tetradecahydrocyclopenta[A]phenanthrene-4,6,8,15-Tetrol (PubChem CID: 162909865)
- 13. (3s,6r,8s,9r,10r,13r,14s,15r,16r,17r)-3-[(2s,3r,4s,5r)-5-Hydroxy-3,4-Dimethoxyoxan-2-Yl]oxy-17-[(E,2r,5r)-7-Hydroxy-5-Methylhept-3-En-2-Yl]-10,13-Dimethyl-1,2,3,6,7,9,11,12,14,15,16,17-Dodecahydrocyclopenta[A]phenanthrene-6,8,15,16-Tetrol (PubChem CID: 162875567)
- 14. (3s,6r,8s,9r,10r,13r,14s,15s,16r,17r)-3-[(2s,3r,4s,5r)-4,5-Dihydroxy-3-Methoxyoxan-2-Yl]oxy-17-[(2r,5r,7s)-7-Hydroxy-5-Propan-2-Yloctan-2-Yl]-10,13-Dimethyl-1,2,3,6,7,9,11,12,14,15,16,17-Dodecahydrocyclopenta[A]phenanthrene-6,8,15,16-Tetrol (PubChem CID: 162888999)
- 15. 1,3,8-Trihydroxy-6-Propyl-9,10-Anthraquinone (PubChem CID: 23265983)
- 16. 2-(2,3-Dihydroxyphenyl)-5,7-Dihydroxy-3-[3,4,5-Trihydroxy-6-[(3,4,5-Trihydroxy-6-Methyloxan-2-Yl)oxymethyl]oxan-2-Yl]oxychromen-4-One (PubChem CID: 53399169)
- 17. 2-(3,4-Dihydroxyphenyl)ethyl (4s,5e,6s)-5-Ethylidene-4-[2-[2-(4-Hydroxyphenyl)ethoxy]-2-Oxoethyl]-6-[(2s,3r,4s,5s,6r)-3,4,5-Trihydroxy-6-(Hydroxymethyl)oxan-2-Yl]oxy-4h-Pyran-3-Carboxylate (PubChem CID: 100926556)
- 18. 2-(4-Hydroxyphenyl)ethyl (4s,5e,6s)-5-Ethylidene-4-[2-[2-(4-Hydroxyphenyl)ethoxy]-2-Oxoethyl]-6-[(2s,3r,4s,5s,6r)-3,4,5-Trihydroxy-6-(Hydroxymethyl)oxan-2-Yl]oxy-4h-Pyran-3-Carboxylate (PubChem CID: 100926557)
- 19. 2-Ethyl-4-Methylphenol (PubChem CID: 77462)
- 20. 2-Hydroxybenzenepropanoic Acid (PubChem CID: 873)
- 21. 3,4,5-Trihydroxybenzoate (PubChem CID: 54675821)
- 22. 3-(3,4-Dihydroxyphenyl)prop-2-Enoate (PubChem CID: 54710367)
- 23. 4-(2-Hydroxyethyl)-2-[4-(2-Hydroxyethyl)phenoxy]phenol (PubChem CID: 86163981)
- 24. 6-Hydroxy-7,8-Dimethoxycoumarin (PubChem CID: 11345068)
- 25. 6-Hydroxyskimmin (PubChem CID: 5088914)
- 26. 7-Hydroxy-2-Oxo-2h-Chromen-6-Yl Hexopyranoside (PubChem CID: 5351506)
- 27. 7-Hydroxy-6-Methoxy-8-[(3r,4s,5s,6r)-3,4,5-Trihydroxy-6-(Hydroxymethyl)oxan-2-Yl]oxychromen-2-One (PubChem CID: 15559341)
- 28. [(2r)-1-(4,5,7-Trihydroxy-9,10-Dioxoanthracen-2-Yl)propan-2-Yl] Sulfate (PubChem CID: 76764019)
- 29. [(2r,3r,5r,6r)-6-[2-(3,4-Dihydroxyphenyl)ethoxy]-5-Hydroxy-2-(Hydroxymethyl)-4-[(2s,3r,4r,5r,6s)-3,4,5-Trihydroxy-6-Methyloxan-2-Yl]oxyoxan-3-Yl] (E)-3-(3,4-Dihydroxyphenyl)prop-2-Enoate (PubChem CID: 45358104)
- 30. [(8bs)-4,8b-Dimethyl-3-(Methylcarbamoyl)-2,3a-Dihydro-1h-Pyrrolo[2,3-B]indol-7-Yl] N-Methylcarbamate (PubChem CID: 3083935)
- 31. [D] Tyrosol (PubChem CID: 10773058)
- 32. Altissimacoumarin F (PubChem CID: 60201876)
- 33. Apigenin (PubChem CID: 5280443)
- 34. Beta-Sitosterol (PubChem CID: 222284)
- 35. Calceolarioside B (PubChem CID: 5273567)
- 36. Campesterol (PubChem CID: 173183)
- 37. Carvone, (+)- (PubChem CID: 16724)
- 38. Cholesterol (PubChem CID: 5997)
- 39. Chryseriol (PubChem CID: 5280666)
- 40. Cichoriin (PubChem CID: 442101)
- 41. Crotonosine (PubChem CID: 12304151)
- 42. Epicatechin (PubChem CID: 72276)
- 43. Esculetin (PubChem CID: 5281416)
- 44. Esculin (PubChem CID: 5281417)
- 45. Esculin Hydrate (PubChem CID: 16211025)
- 46. Excelside B (PubChem CID: 46881042)
- 47. Formononetin (PubChem CID: 5280378)
- 48. Fraxetin (PubChem CID: 5273569)
- 49. Fraxin (PubChem CID: 5273568)
- 50. Guaiacylglycerol Beta-Scopoletinyl Ether (PubChem CID: 121232652)
- 51. Henricioside H2 (PubChem CID: 12135205)
- 52. Hexitol (PubChem CID: 453)
- 53. Hyperasid (PubChem CID: 90657624)
- 54. Isoacteoside (PubChem CID: 6476333)
- 55. Isofucosterol (PubChem CID: 5281326)
- 56. Isolugrandoside (PubChem CID: 5318592)
- 57. Isoquercetin (PubChem CID: 5280804)
- 58. Ligstroside (PubChem CID: 14136859)
- 59. Ligustrazine (PubChem CID: 14296)
- 60. Lugrandoside (PubChem CID: 10054909)
- 61. Mannitol (PubChem CID: 6251)
- 62. Methyl (4s,5z,6r)-4-[2-[2-(3,4-Dihydroxyphenyl)ethoxy]-2-Oxoethyl]-5-Ethylidene-6-[(2s,3r,4s,5s,6r)-3,4,5-Trihydroxy-6-(Hydroxymethyl)oxan-2-Yl]oxy-4h-Pyran-3-Carboxylate (PubChem CID: 53297357)
- 63. Phaeocaulisin E (PubChem CID: 14633000)
- 64. Plantasioside (PubChem CID: 44423103)
- 65. Raspberry Ketone (PubChem CID: 21648)
- 66. Rhamnetin (PubChem CID: 5281691)
- 67. Rutin (PubChem CID: 5280805)
- 68. Sarsasapogenin (PubChem CID: 92095)
- 69. Scopoletin (PubChem CID: 5280460)
- 70. Sedoheptulose (PubChem CID: 5459879)
- 71. Stachyose (PubChem CID: 439531)
- 72. Syringic Acid (PubChem CID: 10742)
- 73. Turmerone (PubChem CID: 14367555)
- 74. Ursolic Acid (PubChem CID: 64945)
- 75. Vanillic Acid (PubChem CID: 8468)
- 1. Arthritis, Rheumatoid
- 2. Asthma
- 3. Brain Edema
- 4. Bronchiectasis
- 5. Cholera
- 6. Constipation
- 7. Coronary Artery Disease
- 8. Crohn Disease
- 9. Cystic Fibrosis
- 10. Diabetes Mellitus
- 11. Glaucoma
- 12. Liver Diseases
- 13. Muscular Dystrophies
- 14. Osteoarthritis
- 15. Pre-Eclampsia
- 16. Psoriasis
Not listed in any formulations.